Literature DB >> 8339399

Molecular forms of atrial natriuretic factor in normal and failing human myocardium.

R J Rodeheffer1, M Naruse, J B Atkinson, K Naruse, J C Burnett, W H Merrill, W H Frist, H Demura, T Inagami.   

Abstract

BACKGROUND: Atrial natriuretic factor (ANF) is produced by myocardial tissue, and the plasma ANF concentration is known to be elevated in congestive heart failure (CHF). Data from animal models indicate that myocardial concentrations of ANF are depleted in CHF, and this has given rise to the hypothesis that CHF is characterized by depletion of stored ANF. To date, the molecular forms of ANF and their concentrations in atrial and ventricular myocardium remain poorly characterized in the normal and the failing human heart. METHODS AND
RESULTS: We measured ANF concentrations in fresh tissue from failing human hearts explanted at the time of cardiac transplantation and from organ donors whose normal hearts could not be used for transplantation. We determined total ANF and alpha, beta, and gamma ANF concentrations in the right and left atrial appendages, atrial free walls, and ventricles. In normal hearts, ANF concentration in the atrial appendages was 40-fold higher than ANF in the rest of the atrial free wall and in the ventricles. In the failing hearts, atrial appendage ANF concentrations increased 5- to 10-fold, and atrial free wall ANF concentrations increased 200-fold. Analysis of molecular forms of ANF demonstrated significant increases in the gamma and beta forms in the left atrial appendage of failing hearts. alpha, beta, and gamma ANF forms were also significantly increased in right and left atrial free wall tissue from failing hearts. In addition, failing hearts were characterized by absolute and relative increases in the precursor form gamma ANF.
CONCLUSIONS: These data from fresh tissues suggest that cardiac ANF stores are not decreased in severe CHF in humans; rather, chronic CHF is characterized by marked increases in atrial ANF tissue concentrations, particularly the beta and gamma ANF forms. These findings are consistent with intracellular accumulation of precursor ANF forms in severe chronic human CHF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339399     DOI: 10.1161/01.cir.88.2.364

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

Review 1.  A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.

Authors:  Gary S Francis; G Michael Felker; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2016-01-26       Impact factor: 24.094

Review 2.  Cardiac imaging for assessment of left atrial appendage stasis and thrombosis.

Authors:  Jorge Romero; Jie J Cao; Mario J Garcia; Cynthia C Taub
Journal:  Nat Rev Cardiol       Date:  2014-06-10       Impact factor: 32.419

3.  Morphological changes evaluation of left atrial appendage in patients with ischaemic heart disease.

Authors:  Abdulwahab Abuderman; Mohammed Abbas
Journal:  Biomed J       Date:  2016-09-29       Impact factor: 4.910

4.  A 79-year-old woman with atrial fibrillation and new onset of heart failure.

Authors:  Birke Schneider; Dirk Nazarenus; Claudia Stöllberger
Journal:  ESC Heart Fail       Date:  2019-03-22

Review 5.  Evidence and Challenges in Left Atrial Appendage Management.

Authors:  Taira Yamamoto; Daisuke Endo; Satoshi Matsushita; Akie Shimada; Keisuke Nakanishi; Tohru Asai; Atsushi Amano
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-07-31       Impact factor: 1.520

Review 6.  Surgical clip closure of the left atrial appendage.

Authors:  Fabrizio Rosati; Gijs E de Maat; Mattia A E Valente; Massimo A Mariani; Stefano Benussi
Journal:  J Cardiovasc Electrophysiol       Date:  2021-08-04       Impact factor: 2.942

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.